The Food and Drug Administration approved the first alternative to the Humira drug, which is the second best-selling medication in the world. Humira is supposed to treat rheumatoid arthritis and inflammatory diseases. Even though the drug is efficient, it is also expensive. Researchers from Amgen Inc developed Amjevita, a similar drug that should be able to have the same effect.
Even though alternative drugs are used in Europe, the United States health system did not use them so much. However, using a cheaper alternative could save billions of dollars for the U.S. health system.
Even though we know that this new drug will be cheaper than Humira, Amgen did not tell any details about the date when it will be launched or about its price. It seems that it will be launched between 2018 and 2022, so we will have to wait until it will be on the market.
Humira brought its developers billions of dollars and it was the most sold drug in the world for many years. The drug was approved in 2002 and it is able to block the substances associated with inflammation.
This new drug approved by FDA should reduce the amount of money the United States in spending on these drugs. From 2010, the sum has doubled and the authorities spend 150 billion dollars. It will be hard for Amgen to convince people to use their product because Americans are not used to using the alternative drug. Moreover, Humira was used for so many years, that people are trusting this drug.
However, there will be a lot of people who will buy it because they had low income or just because they want to try the new product. We could have a surprise about this new drug. It could be more efficient. What we know for sure is that we will have to wait some years before being able to use it.
The developers of Humira filed a case against Amgen because they say this alternative drug violates their patents. They are asking the court to not allow Amjevita on the market, even if FDA approved it. We will see what the court will decide. What do you think? Are they afraid of the new product? Humira has been on the market for a long time and it is the first time FDA approves a similar drug to it.
Image source: Wikipedia